三生国健(688336) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for the third quarter reached ¥252,795,997.87, representing a year-on-year increase of 35.36%[6] - Year-to-date revenue totaled ¥730,604,269.06, with a year-on-year growth of 38.54%[6] - The net profit attributable to shareholders for the third quarter was ¥69,161,561.28, showing a significant increase of 726.66% compared to the same period last year[24] - The net profit attributable to shareholders of the listed company for the first three quarters of 2023 was RMB 163,916,132.74, compared to RMB 1,177,032.01 in the same period of 2022, showing significant growth[35] - The total operating costs for the first three quarters of 2023 were RMB 573,320,875.34, a slight decrease from RMB 578,716,623.28 in the same period of 2022[34] - The company reported a profit from operations of RMB 174,420,210.89, a significant recovery from a loss of RMB 15,126,391.48 in the previous year[35] - The total comprehensive income attributable to the parent company was 168,464,119.97 yuan, up from 15,032,660.22 yuan year-over-year[50] Earnings and Profitability - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥66,531,368.34[24] - The basic earnings per share for the third quarter were ¥0.11, with diluted earnings per share also at ¥0.11[24] - The basic earnings per share for the reporting period was RMB 1,000.00, reflecting a substantial increase[26] - The weighted average return on net assets was 1.45%, an increase of 1.27 percentage points year-on-year[24] - The company reported a basic and diluted earnings per share of 0.27 yuan for the current period, compared to 0.00 yuan in the previous period[50] Research and Development - Research and development expenses amounted to ¥64,867,599.40, which is a decrease of 10.43% compared to the previous year[24] - R&D expenses accounted for 25.66% of operating revenue, down by 13.12 percentage points year-on-year[24] - The company's R&D expenses for the first three quarters of 2023 were RMB 179,648,937.99, down from RMB 216,576,998.56 in the same period of 2022[34] - Research and development expenses accounted for 13.12 percentage points less of operating revenue in the reporting period, indicating a shift towards capitalizing R&D expenditures[26] - The company anticipates continued growth in operating revenue and net profit, supported by ongoing investments in R&D and market expansion strategies[26] Assets and Liabilities - Total assets as of September 30, 2023, were ¥5,128,605,859.65, reflecting a slight increase of 0.59% from the end of the previous year[24] - The equity attributable to shareholders increased to ¥4,776,050,248.51, up by 3.70% compared to the previous year[24] - Total current assets decreased to 2,495,904,342.14 yuan from 2,986,333,982.04 yuan year-over-year[45] - The company's total assets increased to 5,128,605,859.65 yuan compared to 5,098,403,734.80 yuan at the end of the previous year[46] - The total liabilities decreased to 367,895,802.45 yuan from 498,881,958.65 yuan year-over-year[46] - The total equity attributable to the parent company increased to 4,776,050,248.51 yuan from 4,605,846,042.52 yuan year-over-year[47] Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 108.51% due to higher sales collection and improved turnover rates of operating receivables[26] - Operating cash flow for the first three quarters of 2023 reached ¥292,832,357.70, a significant increase of 108.4% compared to ¥140,442,228.33 in the same period of 2022[52] - Total cash inflow from operating activities was ¥840,284,676.72, up 16.3% from ¥722,453,039.85 in the previous year[52] - Cash received from sales of goods and services amounted to ¥809,781,587.59, an increase of 17.8% from ¥686,885,098.15 in the same period of 2022[51] - The net cash flow from investment activities was -¥79,171,982.15, an improvement from -¥399,764,887.91 in the same period last year[52] - Cash outflow for debt repayment was ¥150,000,000.00, with no corresponding figure reported for the previous year[52]